The stratification of results by disease stage, as shown in Table 1, offers critical insights into the differing expression patterns of lncRNA ANRIL across various levels of endometriosis severity, underscoring its potential as a therapeutic target or diagnostic marker for advanced disease. The gene discussed is CDKN2B-AS1; the disease is endometriosis.